Table 2.
Five-year observed survival (OS) and net survival (NS) by sex in adult patients diagnosed with cancer in Spain in 2008–2013.
| Cancer Group | Men | Women | Both | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of Cases | OS (95% CI), % | NS (95% CI), % | Number of Cases | OS (95% CI), % | NS (95% CI), % | Number of Cases | OS (95% CI), % | NS (95% CI), % | |
| Oral cavity and pharynx | 5573 | 37.2 (35.9–38.6) | 40.5 (39.0–42.0) | 1733 | 53.1 (50.5–55.5) | 57.6 (54.7–60.6) | 7306 | 41.0 (39.8–42.2) | 44.5 (43.2–45.9) |
| Esophagus | 2619 | 11.5 (10.2–12.9) | 12.7 (11.3–14.2) | 472 | 13.8 (10.7–17.3) | 14.6 (11.0–18.1) | 3091 | 11.9 (10.7–13.1) | 13.0 (11.7–14.4) |
| Stomach | 6533 | 20.8 (19.8–21.8) | 24.0 (22.7–25.2) | 3880 | 23.3 (21.9–24.7) | 26.1 (24.5–27.7) | 10,413 | 21.7 (20.9–22.6) | 24.8 (23.8–25.8) |
| Colon | 18,121 | 51.2 (50.4–52.0) | 60.5 (59.5–61.5) | 12,488 | 53.3 (52.3–54.2) | 60.2 (59.1–61.3) | 30,609 | 52.1 (51.5–52.7) | 60.4 (59.7–61.1) |
| Rectum | 9580 | 51.2 (50.1–52.3) | 59.0 (57.7–60.4) | 5136 | 53.9 (52.4–55.3) | 59.7 (57.9–61.4) | 14,716 | 52.1 (51.3–53.0) | 59.3 (58.2–60.3) |
| Liver | 5440 | 16.1 (15.1–17.2) | 17.6 (16.4–18.8) | 2028 | 10.3 (8.8–11.8) | 11.2 (9.5–12.8) | 7468 | 14.6 (13.7–15.5) | 15.9 (14.9–16.9) |
| Gallbladder and bile ducts | 1584 | 14.8 (12.9–16.7) | 17.2 (14.9–19.5) | 1766 | 12.0 (10.4–13.7) | 14.2 (12.1–16.3) | 3350 | 13.3 (12.1–14.6) | 15.6 (14.1–17.2) |
| Pancreas | 4427 | 5.7 (5.0–6.5) | 6.2 (5.4–7.1) | 3881 | 6.3 (5.5–7.2) | 6.9 (5.9–7.8) | 8308 | 6.0 (5.5–6.6) | 6.5 (5.9–7.2) |
| Larynx | 4460 | 55.2 (53.6–56.7) | 61.5 (59.7–63.3) | 355 | 64.7 (59.1–69.8) | 68.0 (62.2–73.8) | 4815 | 55.9 (54.3–57.3) | 62.0 (60.3–63.7) |
| Lung | 26,981 | 10.9 (10.5–11.3) | 12.1 (11.6–12.6) | 6352 | 17.3 (16.3–18.4) | 18.0 (16.9–19.2) | 33,333 | 12.1 (11.7–12.5) | 13.2 (12.8–13.6) |
| Skin melanoma | 3140 | 70.9 (69.2–72.6) | 80.3 (78.1–82.5) | 3480 | 81.4 (79.9–82.7) | 87.5 (85.7–89.3) | 6620 | 76.4 (75.3–77.5) | 84.1 (82.7–85.5) |
| Breast (women) | 34,294 | 82.0 (81.6–82.5) | 87.3 (86.8–87.9) | 34,294 | |||||
| Cervix uteri | 2726 | 65.8 (63.9–67.6) | 67.6 (65.7–69.6) | 2726 | |||||
| Corpus uteri | 7432 | 70.2 (69.1–71.3) | 75.1 (73.8–76.4) | 7432 | |||||
| Ovary and annexes | 4199 | 43.0 (41.3–44.6) | 44.7 (43.0–46.4) | 4199 | |||||
| Prostate | 38,929 | 78.0 (77.5–78.4) | 90.0 (89.4–90.6) | 38,929 | |||||
| Testicle | 1671 | 95.1 (93.9–96.1) | 95.9 (94.8–97.0) | 1671 | |||||
| Kidney | 5069 | 58.5 (57.0–59.9) | 65.4 (63.6–67.2) | 2374 | 59.6 (57.4–61.6) | 64.1 (61.7–66.5) | 7443 | 58.8 (57.6–60.0) | 65.0 (63.5–66.4) |
| Urinary bladder | 20,022 | 60.3 (59.5–61.0) | 70.8 (69.9–71.8) | 3973 | 61.6 (60.0–63.2) | 70.7 (68.6–72.8) | 23,995 | 60.5 (59.8–61.1) | 70.8 (69.9–71.7) |
| Brain | 2613 | 13.5 (12.2–14.9) | 13.9 (12.5–15.4) | 2104 | 14.0 (12.4–15.6) | 14.3 (12.7–15.9) | 4717 | 13.7 (12.7–14.8) | 14.1 (13.0–15.2) |
| Thyroid | 1186 | 84.8 (82.5–86.9) | 88.9 (86.5–91.4) | 4151 | 93.0 (92.1–93.7) | 95.3 (94.5–96.2) | 5337 | 91.2 (90.4–92.0) | 93.9 (93.1–94.8) |
| Hodgkin lymphoma | 1026 | 78.5 (75.8–81.0) | 81.1 (78.3–83.8) | 725 | 82.4 (79.4–85.1) | 83.5 (80.6–86.5) | 1751 | 80.2 (78.1–82.0) | 82.1 (80.0–84.1) |
| Non-Hodgkin lymphoma | 5188 | 57.6 (56.1–59.0) | 63.8 (62.1–65.4) | 4395 | 62.2 (60.7–63.7) | 66.7 (64.9–68.4) | 9583 | 59.7 (58.6–60.7) | 65.1 (63.9–66.3) |
| Myeloma | 1989 | 35.1 (32.8–37.4) | 40.2 (37.4–43.0) | 1747 | 41.2 (38.7–43.7) | 45.0 (42.2–47.9) | 3736 | 38.0 (36.3–39.7) | 42.5 (40.5–44.5) |
| Acute lymphoid leukemia | 189 | 36.5 (29.5–43.6) | 38.0 (30.6–45.4) | 147 | 32.1 (24.5–39.9) | 32.7 (24.6–40.7) | 336 | 34.6 (29.4–39.8) | 35.7 (30.2–41.1) |
| Chronic lymphoid leukemia | 1446 | 61.4 (58.6–64.0) | 73.1 (69.4–76.9) | 995 | 64.1 (60.8–67.1) | 74.2 (70.1–78.2) | 2441 | 62.5 (60.4–64.5) | 73.6 (70.8–76.3) |
| Acute myeloid leukemia | 1192 | 19.3 (17.0–21.7) | 20.1 (17.6–22.6) | 1022 | 25.9 (23.1–28.7) | 26.3 (23.3–29.3) | 2214 | 22.3 (20.5–24.2) | 22.9 (21.0–24.9) |
| Chronic myeloid leukemia | 366 | 69.9 (64.7–74.4) | 75.1 (69.5–80.8) | 240 | 70.3 (63.7–75.9) | 74.2 (67.0–81.3) | 606 | 70.0 (66.0–73.7) | 74.8 (70.4–79.2) |
| Leukemia NOS and others | 658 | 32.8 (28.9–36.8) | 37.8 (32.5–43.1) | 405 | 30.0 (25.1–35.0) | 33.2 (27.3–39.1) | 1063 | 31.7 (28.6–34.8) | 36.0 (32.0–40.0) |
| All cancers a | 184,991 | 47.4 (47.1–47.6) | 54.3 (54.0–54.6) | 123,769 | 57.4 (57.1–57.7) | 62.0 (61.6–62.3) | 308,760 | 51.4 (51.2–51.6) | 57.4 (57.2–57.6) |
Survival estimates are non-age standardized. Abbreviations: NOS, not otherwise specified. a Excluding non-melanoma skin cancer.